Video: Cutera's Pearl Fractional Laser Answers Need for More Youthful Eyes
Posted on: Wednesday, 27 May 2009, 08:00 CDT
(Photo: http://www.newscom.com/cgi-bin/prnh/20090527/NY22813 )
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/cutera/38548/
"Pearl Fractional is a unique and outstanding treatment option for the delicate periorbital area, which often shows the first signs of aging and can be the most challenging to treat," said
Physicians traditionally treat photo-damaged skin around the eyes with spot laser treatments and dermal fillers. The new approach, pioneered by Dr. Biesman, not only uses Pearl Fractional around the eyes, but directly over the eyelids and under the eyes too.
Dr. Biesman notes that the procedure is especially popular with patients who are approaching a milestone. "A lot of my patients come to me on the 4s and the 9s - 34, 39, 44, 49," he said. "My patients are very pleased that they see immediate, noticeable improvement in a single treatment, with very little recovery time."
Pearl Fractional, utilizing a specialized patented 2790 nm wavelength, received FDA clearance in 2008 and offers physicians a new and beneficial approach to resurfacing the skin. As with all aesthetic procedures, patients should consult a physician experienced in aesthetic laser procedures to ensure that their treatment is safe and effective.
About Cutera, Inc.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to successfully develop, manufacture, market, sell and service new products worldwide to both its installed base and new customers are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include its ability to increase revenue, manage expenses and improve sales productivity and performance worldwide; its ability to successfully develop and acquire new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to its operations; government regulatory actions; general economic conditions; and those other factors described in the section entitled, "Risk Factors," in its most recent Form 10-Q as filed with the Securities and Exchange Commission on
SOURCE Cutera, Inc.
Source: PR Newswire
Related Articles
- Los Angeles Clinic (laserandveinclinic.com) Offers the Latest Laser Skin Rejuvenation Treatments
- Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND
- Cutera Launches Its New Pearl Fractional Device
- River Hawk CEO Outlines Capital Structure and Forward-Looking Plan
- BIO Applauds House Passage of Forward-Looking Farm Bill
- BIO Commends House Agriculture Committee on Forward-Looking Farm Bill
- Westinghouse Lauds Progress Energy for Proactive, Forward-Looking Approach to Nuclear Fleet Expansion
- Laser & Varicose Vein Treatment Center Achieves National Quality Approval
- I Looked at Patients and Decided Who Was to Live and Who Was to Die
User Comments (0)

RSS Feeds